The United States Gastroparesis Market is expected to account for a significant share of the global market, driven by the country’s high prevalence of diabetes, obesity, and gastrointestinal disorders. The increasing number of patients diagnosed with diabetic gastroparesis, coupled with growing awareness of digestive health, is fueling demand for advanced diagnostic and treatment solutions. The United States benefits from a well-established healthcare infrastructure, strong reimbursement policies, and the presence of leading pharmaceutical and medical device companies investing in innovative therapies. Ongoing clinical trials, increasing research into novel prokinetic drugs and gastric electrical stimulation devices, and expanding adoption of minimally invasive treatment approaches are further supporting market growth.
Gastroparesis Market Trends
The Gastroparesis Market trends indicate significant growth opportunities driven by increasing disease awareness, continuous innovation in gastrointestinal therapeutics, and expanding clinical research activities. The Gastroparesis Market size is projected to reach US$ 7.39 billion by 2031 from US$ 5.03 billion in 2023, registering a CAGR of 4.9% during 2023–2031. Rising healthcare expenditure, improved diagnostic capabilities, and growing investments in personalized treatment approaches are expected to accelerate market growth. Furthermore, ongoing regulatory approvals, strategic collaborations, and advancements in drug development continue to strengthen the competitive landscape while creating new opportunities for market participants.
Download Sample PDF: https://www.theinsightpartners.com/sample/TIPRE00008992
Why Is the Rising Prevalence of Diabetes Driving the Gastroparesis Market?
One of the most significant growth drivers of the Gastroparesis Market is the increasing prevalence of diabetes worldwide. Diabetic gastroparesis remains one of the most common complications associated with long-term diabetes, particularly among patients with poorly controlled blood glucose levels. As the global diabetic population continues to increase, healthcare providers are diagnosing a larger number of gastroparesis cases requiring long-term disease management.
Growing awareness regarding gastrointestinal complications associated with diabetes has encouraged earlier diagnosis and timely therapeutic intervention. Healthcare professionals are increasingly recommending gastric emptying studies, advanced imaging technologies, and specialized treatment plans to improve symptom management and reduce disease progression. This growing patient population continues to support consistent market demand.
How Are Innovative Treatment Options Transforming the Gastroparesis Market?
Continuous innovation in pharmaceutical therapies and medical technologies is reshaping the Gastroparesis Market. Pharmaceutical companies are investing heavily in the development of novel prokinetic agents, antiemetic medications, and targeted therapies designed to improve gastric motility while minimizing adverse effects. Clinical trials evaluating new therapeutic candidates continue to expand treatment options for patients with chronic symptoms.
Medical device innovation is also creating substantial growth opportunities. Gastric electrical stimulation devices, minimally invasive endoscopic procedures, and advanced nutritional support technologies are improving patient outcomes and expanding treatment possibilities. In addition, digital healthcare solutions, remote patient monitoring, and artificial intelligence-assisted clinical decision-making are enhancing disease management and supporting personalized care strategies.
Market Trends and Growth Analysis by Geography
The Gastroparesis Market demonstrates varying growth patterns across major geographic regions. North America continues to dominate the market owing to its advanced healthcare infrastructure, high prevalence of diabetes, increasing adoption of innovative gastrointestinal therapies, and strong pharmaceutical research activities. The presence of leading biotechnology companies and favorable reimbursement policies further support regional market growth.
Europe represents another significant market driven by expanding healthcare investments, increasing awareness of gastrointestinal disorders, and growing research collaborations. Countries such as Germany, France, Italy, and the United Kingdom continue investing in advanced diagnostic technologies and innovative treatment approaches.
The Asia Pacific region is expected to witness the fastest growth during the forecast period due to rising diabetes prevalence, improving healthcare infrastructure, increasing healthcare expenditure, and expanding access to specialized gastrointestinal care in countries including China, India, Japan, and South Korea. Latin America and the Middle East & Africa are also expected to experience gradual growth as healthcare accessibility and disease awareness continue to improve.
Expanding Research and Development Activities
Research and development remain central to the evolution of the Gastroparesis Market. Pharmaceutical companies, academic institutions, and biotechnology organizations are actively collaborating to develop innovative therapies with improved safety and efficacy profiles. Clinical studies evaluating new drug formulations, regenerative medicine approaches, and precision medicine strategies are expected to broaden future treatment options.
Growing investments in biomarker research, gastrointestinal microbiome studies, and personalized medicine are also creating new opportunities for therapeutic innovation. These advancements are expected to improve patient outcomes while supporting long-term market expansion.
Challenges Affecting the Gastroparesis Market
Despite positive growth prospects, several challenges continue to influence the Gastroparesis Market. Delayed diagnosis due to symptom overlaps with other gastrointestinal disorders, limited availability of highly effective treatment options, and variability in patient response to existing therapies remain significant concerns. Additionally, regulatory approval requirements, high research and development costs, and limited awareness in developing countries may restrain market growth. Nevertheless, continuous innovation and increasing healthcare investments are expected to address these challenges over time.
Top Players in the Gastroparesis Market
- Evoke Pharma
- Bausch Health Companies Inc.(Salix Pharmaceuticals, Ltd.)
- Johnson And Johnson Services, Inc.
- Allergan Plc
- Neurogastrx, Inc.
- Teva Pharmaceutical Industries Ltd
- Pfizer Inc.
- ANI Pharmaceuticals, Inc.
- Ipca Laboratories Ltd.
- Cinrx Pharma, LLC (Cindome Pharma)
These leading companies are focusing on strategic partnerships, clinical research, product innovation, and geographic expansion to strengthen their market presence and address the growing demand for effective gastroparesis treatment solutions.
Future Outlook
The future of the Gastroparesis Market appears promising as healthcare providers continue emphasizing early diagnosis, personalized treatment, and improved patient outcomes. Advances in pharmaceutical development, gastric stimulation technologies, minimally invasive procedures, and digital healthcare solutions are expected to drive sustained market growth through 2031. Increasing investments in gastrointestinal research, expanding clinical trials, and rising awareness of digestive health will further accelerate innovation. As precision medicine and patient-centered care become increasingly important, the market is well positioned for long-term global expansion.
Also Available in: Korean | German | Japanese | French | Chinese | Italian | Spanish
Related Reports:
Colistin Market Demand, Size & Forecast by 2034
Regenerative Medicine Market Growth, Trends, Revenue & Forecast 2025-2031
About Us
The Insight Partners is a one-stop provider of actionable industry research and intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Healthcare IT, Manufacturing and Construction, Medical Devices, Technology, Media and Telecommunications, Food and Beverages, Consumer Goods, and Chemicals and Materials.
Contact US
Contact Person: Ankit Mathur
Phone: +1-646-491-9876
E-mail : sales@theinsightpartners.com
